Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

XTL Biopharmaceuticals set to acquire technology being developed for cartilage-related diseases

Nov. 7, 2011

Atlab Pharma and BZL Biologics enter licensing agreement for [177Lu]-J591

Nov. 4, 2011

BMS and Aslan enter agreement for anticancer compound

Nov. 4, 2011

ExonHit extends strategic collaboration with Allergan

Nov. 3, 2011

Furiex acquires exclusive license to develop MuDelta

Nov. 3, 2011

AgonOx and MedImmune join to develop TNF receptor superfamily member 4 agonists

Nov. 3, 2011

MorphoSys and Shionogi extend HuCAL research partnership

Nov. 2, 2011

Takara Bio to develop gene therapy for non-Hodgkin's lymphoma

Nov. 2, 2011

Oxford BioMedica and Mayo Clinic to collaborate on gene therapy for chronic glaucoma

Oct. 31, 2011

Biogen Idec and Portola enter collaboration for SYK inhibitors

Oct. 31, 2011

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...